These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Lopes LB, Ferreira DA, de Paula D, Garcia MT, Thomazini JA, Fantini MC, Bentley MV. Pharm Res; 2006 Jun 15; 23(6):1332-42. PubMed ID: 16715364 [Abstract] [Full Text] [Related]
8. Towards the development of a RNAi-based topical treatment for psoriasis: Proof-of-concept in a 3D psoriasis skin model. Desmet E, Van Gele M, Grine L, Remaut K, Lambert J. Exp Dermatol; 2018 May 15; 27(5):463-469. PubMed ID: 28833576 [Abstract] [Full Text] [Related]
13. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S, Koburger I, John M, Czubayko F, Hadwiger P, Vornlocher HP, Aigner A. J Gene Med; 2010 Mar 15; 12(3):287-300. PubMed ID: 20052738 [Abstract] [Full Text] [Related]
14. Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis. Nemati H, Ghahramani MH, Faridi-Majidi R, Izadi B, Bahrami G, Madani SH, Tavoosidana G. J Control Release; 2017 Dec 28; 268():259-268. PubMed ID: 29074408 [Abstract] [Full Text] [Related]
15. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. Dorrani M, Garbuzenko OB, Minko T, Michniak-Kohn B. J Control Release; 2016 Apr 28; 228():150-158. PubMed ID: 26965957 [Abstract] [Full Text] [Related]
16. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Günther M, Lipka J, Malek A, Gutsch D, Kreyling W, Aigner A. Eur J Pharm Biopharm; 2011 Apr 28; 77(3):438-49. PubMed ID: 21093588 [Abstract] [Full Text] [Related]
17. Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs. Silvestrini AVP, Garcia Praça F, Leite MN, de Abreu Fantini MC, Frade MAC, Badra Bentley MVL. Int J Pharm; 2023 Jun 10; 640():123019. PubMed ID: 37149114 [Abstract] [Full Text] [Related]
18. Topical delivery of siRNA into skin using SPACE-peptide carriers. Chen M, Zakrewsky M, Gupta V, Anselmo AC, Slee DH, Muraski JA, Mitragotri S. J Control Release; 2014 Apr 10; 179():33-41. PubMed ID: 24434423 [Abstract] [Full Text] [Related]
19. Current Non-viral siRNA Delivery Systems as a Promising Treatment of Skin Diseases. Rosa J, Suzuki I, Kravicz M, Caron A, Pupo AV, Praça FG, Bentley MVLB. Curr Pharm Des; 2018 Apr 10; 24(23):2644-2663. PubMed ID: 30084329 [Abstract] [Full Text] [Related]